R 873

Drug Profile

R 873

Latest Information Update: 14 Nov 2006

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Roche
  • Class Erectile dysfunction therapies
  • Mechanism of Action G protein-coupled receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Erectile dysfunction

Most Recent Events

  • 19 Oct 2006 Discontinued - Phase-II for Erectile dysfunction in Switzerland (unspecified route)
  • 04 Jul 2006 Phase-II clinical trials in Erectile dysfunction in Switzerland (unspecified route)
  • 31 Dec 2004 Phase-I clinical trials in Erectile dysfunction in Switzerland (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top